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ABSTRACT
Background People affected by homelessness, 
imprisonment, substance use, sex work or severe 
mental illness experience substantial excess ill health 
and premature death. Though these experiences often 
co- occur, health outcomes associated with their overlap 
have not previously been reviewed. We synthesised 
existing evidence on mortality, morbidity, self- rated 
health and quality of life among people affected by more 
than one of these experiences.
Methods In this systematic review and meta- analysis, 
we searched Medline, Embase, and PsycINFO for peer- 
reviewed English- language observational studies from 
high- income countries published between 1 January 
1998 and 11 June 2018. Two authors undertook 
independent screening, with risk of bias assessed using 
a modified Newcastle- Ottawa Scale. Findings were 
summarised by narrative synthesis and random- effect 
meta- analysis.
Results From 15 976 citations, 2517 studies underwent 
full- text screening, and 444 were included. The most 
common exposure combinations were imprisonment/
substance use (31% of data points) and severe 
mental illness/substance use (27%); only 1% reported 
outcomes associated with more than two exposures. 
Infections were the most common outcomes studied, 
with blood- borne viruses accounting for 31% of all data 
points. Multiple exposures were associated with poorer 
outcomes in 80% of data points included (sign test for 
effect direction, p<0.001). Meta- analysis suggested 
increased all- cause mortality among people with multiple 
versus fewer exposures (HR: 1.57 and 95% CI: 1.38 to 
1.77), though heterogeneity was high.
Conclusion People affected by multiple exclusionary 
processes experience profound health inequalities, 
though there are important gaps in the research 
landscape. Addressing the health needs of these 
populations is likely to require co- ordinated action across 
multiple sectors, such as healthcare, criminal justice, drug 
treatment, housing and social security.
PROSPERO registration number CRD42018097189.
INTRODUCTION
Social exclusion can be defined as the processes by 
which some individuals or social groups are deprived 
of resources, rights or opportunities to partici-
pate in the activities and relationships available to 
most people in society.1 2 Homelessness, imprison-
ment, substance use, sex work and severe mental 
illness (SMI) are experiences commonly associated 
with social exclusion, which often co- occur.3 The 
magnitude of this overlap varies between contexts, 
but as an example, recent studies from the UK esti-
mate that approximately 1·5 per thousand people 
experience homelessness, justice involvement and 
problem substance use in a given year.4 5
People affected by any one of these experiences 
are known to have much higher rates of ill health 
and premature death than the rest of the popula-
tion.3 For instance, a previous review undertaken by 
our team found that standardised mortality ratios 
among people with experience of homelessness, 
imprisonment, substance use or sex work compared 
with the general population were between 8 and 
12.3 That review examined health outcomes associ-
ated with these experiences individually and did not 
investigate their co- occurrence.
There is good reason to hypothesise that multiple 
forms of exclusion may be associated with poorer 
health. First, intersectionality approaches have 
highlighted how overlapping forms of disadvan-
tage can interact to influence an individual’s social 
experience and therefore their health.6 Second, 
some forms of multiple exclusions appear to be 
associated with adverse outcomes, whereas for 
others, the evidence is mixed. For instance, among 
people released from prison, substance use—but 
not psychiatric history—is a consistent risk factor 
for mortality.7 8
To our knowledge, the association between 
multiple forms of exclusion and health outcomes 
has not previously been reviewed. Understanding 
this association is increasingly important given 
rising rates of homelessness, imprisonment and 
drug- related harms across a number of high- income 
countries.9–12 We aimed to synthesise evidence 
from high- income countries of the association 
between lifetime exposure to more than one of the 
following: homelessness, imprisonment, substance 
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1. All- cause and cause- specific mortality.
2. Morbidity.
3. Self- rated health or quality of life.
We chose to consider SMI as an additional exposure to those 
included in our previous review, as in some contexts it over-
laps substantially with the other experiences of interest13–15 and 
is often associated with both social exclusion16 and premature 
morbidity and mortality.17
METHODS
This systematic review and meta- analysis were conducted 
according to a protocol registered with PROSPERO in advance 
of study initiation.
Populations of interest
Exposures of interest in this review were chosen on the grounds 
that they are among the most extreme and most commonly 
co- occurring forms of social exclusion in high- income countries: 
their impacts are likely to be less variable over time and place 
than experiences, which are more closely allied to individual 
identity, such as ethnicity, migration or sexual minority status. 
This choice was also informed by continuity with a previous 
review undertaken by our team3 and a forthcoming cohort study 
drawing on administrative data sources.
Study participants comprised people with a lifetime history of 
more than one of the following:
 ► Homelessness (including people who are rough sleeping or 
unstably/marginally housed).
 ► Imprisonment.
 ► Substance use (other than alcohol, cannabis or image/
performance- enhancing drugs).
 ► Sex work (including transactional sexual relationships, ie, 
sex in exchange for food, accommodation and drugs).
 ► SMI, defined as schizophrenia spectrum disorders, other 
psychotic disorders and/or bipolar disorder or according 
to the primary study’s definition of “serious” or “severe” 
mental illness.
Alcohol was not included in the exposure definition for 
substance use, as the legality and ubiquity of alcohol in many 
high- income countries mean that its use is less stigmatised and 
less closely associated with social exclusion.18 Cannabis was 
similarly excluded given the legalisation or decriminalisation of 
its use in many high- income countries.19 Where a study referred 
to substance use without distinguishing between these catego-
ries, studies were included.
Studies were excluded if participants were recruited from 
secondary healthcare settings or on the basis of specific health 
conditions or healthcare utilisation (other than for SMI or 
substance use). The comparator group was defined as people 
with fewer or none of the exposures of interest. Given the 
number of studies retrieved, it was decided at the full- text stage 
to exclude data points without any comparison group.
Outcomes
The outcomes of interest were mortality (all- cause or cause- 
specific, categorised according to International Classification 
of Diseases 10th revision (ICD-10) chapters); morbidity (based 
on clinical diagnosis, hospitalisation, validated diagnostic tool 
or self- report, categorised according to ICD-10); and quality of 
life, health- related quality of life and self- rated health (based on 
formal measures such as SF-36 (36 Item Short- Form Survey) or 
EQ- 5D). We excluded outcomes relating to the perinatal period, 
health behaviours, engagement with preventative health services 
and prognosis or treatment success. Outcomes that clearly 
preceded exposures of interest (eg, disorders of early childhood) 
were not eligible. Both absolute and relative outcome measures 
were eligible for inclusion.
Study design
Eligible study designs were cross- sectional, case–control and 
cohort studies and baseline data from interventional studies. 
Systematic reviews were eligible for inclusion if they had a clearly 
specified review question, reported a search strategy including 
more than one database and used explicit inclusion criteria to 
select studies.
Publication characteristics
Given that the relationship between the exposures and outcomes 
of interest is at least partly dependent on context (eg, social 
policy, healthcare provision, public attitudes and other factors), 
we restricted our search to studies published in the last two 
decades (from 01 January 1998 to 6 November 2018) and in the 
English language from high- income countries (World Bank clas-
sification),20 to maximise the relevance of the evidence retrieved 
to current policy and practice in those countries. Conference 
papers, theses, correspondence and editorials or other commen-
tary were excluded.
Searches, screening and data extraction
Medline, Embase and PsycINFO were searched on 6 November 
2018 using a search strategy developed with an information 
specialist and detailed in online supplemental appendix 1. 
Screening was undertaken in Covidence, following automatic 
and manual deduplication. All title/abstracts were screened for 
inclusion by ET and independently by a second reviewer. A 20% 
sample of the resulting full texts underwent double screening; 
the remainder was single- screened by ET. The kappa statistic for 
the double- screened sample was 0.93.
Data extraction of studies eligible for inclusion was under-
taken by ET and checked independently by a second reviewer 
using a standardised form, available in online supplemental 
appendix 1. We contacted authors where eligible data points 
were identified but not published in an extractable format (eg, 
graphical presentation only). Risk of bias (RoB) was assessed 
independently by ET and a second reviewer at the outcome 
level, using an adapted version of the Newcastle- Ottawa Scale 
for non- randomised studies (online supplemental appendix 1). 
Screening conflicts and discrepancies in data extraction or RoB 
assessment were resolved by discussion and, where necessary, the 
adjudication of a third reviewer (SVK).
For completeness, where systematic reviews were identified, 
we reviewed these to identify any original studies not included 
in the original searches, which appeared to report relevant 
outcomes for >more than one exposure group in combina-
tion.21 These underwent title and abstract screening followed 
by full- text review as per studies retrieved by searches: of 104 
potentially eligible studies identified in this way, only seven met 
inclusion criteria and were included in the final analysis.
Studies were reviewed to identify duplicate data where results 
from a single research study were presented in separate publi-
cations: where this occurred, the study with the largest or most 
representative sample size was included. Potentially overlapping 
data points (eg, reporting both absolute and relative measures 
for the same population and outcome or reporting the same 
outcome for non- mutually exclusive substance use subgroups) 
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were deduplicated using the criteria outlined in online supple-
mental appendix 1.
Data synthesis
Narrative synthesis of findings was undertaken according to 
a prespecified protocol, summarising the characteristics of 
included studies: the range, direction, and size of associations 
reported; the results of RoB assessment; and key gaps in the 
literature.22 Effect direction plots were created as a visual aid 
to synthesis and sign tests used to test the null hypothesis of 
equivalent outcomes between multiple excluded groups and 
comparators.23 All visualisations were created in R V.3.6.3 using 
the packages ggplot2 and rworldmap.
Meta- analyses were undertaken to compare multiple with 
fewer exposures in order to explore the overarching review 
question of whether multiple exclusions is associated with poorer 
health. We anticipated substantial heterogeneity and therefore 
planned in advance to use random- effect models, using the 
metan command in Stata V.15. These were carried out separately 
by effect measure as most studies reported only point estimates 
without absolute numbers, precluding synthesis across multiple 
effect measures. Funnel plots were used to visually assess the 
potential of publication bias for key outcomes reported in the 
manuscript.
RESULTS
Figure 1 shows the study selection figure. After deduplication, a 
total of 444 studies were included, yielding 1480 data points (ie, 
effect estimates for a unique population and comparator combi-
nation) in total. Details of included studies are in online supple-
mental appendix 2.
Thirty countries were represented (online supplemental 
figure A3.1 in appendix 3), though the majority of studies were 
carried out in the USA (n=164; 37%), Canada (n=57; 13%), 
the UK (n=41; 9%) or Australia (n=39; 9%). Most studies 
were cross- sectional (n=327; 74%); only 23% studies (n=103) 
reported longitudinal data. With regard to RoB, 63% of data 
points (n=932/1480) were assessed as having low RoB, though 
this varied by study design (online supplemental table A3.1 in 
appendix 3).
The most common exposure combinations were imprison-
ment/substance use and SMI/substance use, accounting for 31% 
(n=465) and 27% (n=393) of data points, respectively, followed 
by homelessness/substance use (19%; n=283). Only four of the 
possible 10 combinations of three exposures had any available 
data points; no data points were identified relating to four or 
more exposures (figure 2).
With regard to outcomes, 77% (n=1139) data points are 
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Figure 1 PRISMA flow chart.
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to self- reported health or quality of life. The most common 
ICD-10 chapters were infections (chapter 1: 40%; n=587), 
mental and behavioural disorders (chapter 5: 16%; n=236) and 
external causes (chapters 19 and 20 combined: 15%; n=227).
Figure 3 shows the distribution of data points by exposure 
combination and outcome category (organised by ICD-10 
chapter). It illustrates the dominance of a limited number of 
outcome types—above all, infectious diseases—and the lack of 
any data for some exposure combinations on common condi-
tions such as circulatory, respiratory and metabolic disorders. 
Across all exposure combinations, blood- borne viruses (BBV) 
accounted for 31% (n=456) of total data points (online supple-
mental figure A3.2 in appendix 3).
Overall, 80% (n=1190/1480) of data points showed an 
association between multiple exposures and poorer health 
outcomes: after restricting to studies at low RoB, this rose to 
86% (n=801/932). Sign testing of effect direction gave p values 
of <0.001 in both cases, providing evidence to reject the null 
hypothesis of no association.
In presenting the results of our narrative and quantita-
tive synthesis, we focus on all- cause mortality; cause- specific 
mortality and morbidity from infections, external causes, and 
non- communicable diseases (NCDs); and self- rated health and 
quality of life. Effect direction plots and meta- analysis results 
for other outcomes are shown in online supplemental appendix 
3 and 4, respectively. Heterogeneity was high in most meta- 
analyses undertaken and did not appear to be explained by 
assessed RoB.
With regard to all- cause mortality, 79% (n=75/95) data points 
showed an association between multiple exposures and increased 
risk (sign test for effect direction <0.001; figure 4A). Figure 4B 
shows the pooled results for studies reporting HRs, the most 
commonly reported effect measure. The pooled point estimate 
of 1·57 (95% CI: 1·38 to 1·77) was similar to those obtained for 
other effect measures, and exclusion of studies at high RoB did 
not materially affect the results (online supplemental appendix 
4).
Figure 2 Number of data points by exposure combination and study design.
Figure 3 Heat map showing distribution of data points by exposure combination and outcome category.
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Figure 4 (A) Summary effect direction plot for all- cause mortality. (B). Forest plot for meta- analysis of data points reporting all- cause mortality 
using HRs, by exposure combination.
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For external- cause mortality (ICD-10 chapters 19 and 20), 
again, the majority (81%; n=60/74) of data points suggested 
greater risk among those with multiple versus fewer expo-
sures (sign test for effect direction p<0.001; figure 5A). Pooled 
measures indicated a stronger association than for all- cause 
mortality, evident across all exposure combinations (figure 5B). 
Again, results were similar across effect measures and after strati-
fication by assessed RoB (online supplemental appendix 4). Simi-
larly, with regard to BBV prevalence, 87% (n=394/452) data 
points showed an association between multiple exposures and 
higher prevalence (sign test for effect direction p<0.001; online 
supplemental appendix 3). Pooled measures indicated a strong 
association including after stratification by assessed RoB (online 
supplemental appendix 4).
Fewer data points were available for NCDs: effect direction 
plots and sign testing did not identify an association between 
multiple exclusions and NCDs overall (online supplemental 
appendix 3), though the burden of respiratory disease did 
appear to be significantly higher (sign test p=0.016). Variation 
in outcome measures and time periods meant that meta- analyses 
were small and potentially underpowered but showed similar 
results (online supplemental appendix 4).
With regard to self- rated health and quality of life, 71% 
(n=71/100) data points for this outcome type suggested poorer 
outcomes among people experiencing multiple exclusions (sign 
test p<0.001), but this proportion varied by exposure combina-
tions (online supplemental appendix 3). Meta- analysis of these 
outcomes was not possible due to variation in the instruments 
used and limitations in reporting.
Relatively few data points were available for gender- stratified 
analyses. Exploratory analyses did not suggest a consistent differ-
ence between genders in associations between multiple exclu-
sions and health outcomes (online supplemental appendix 4).
DISCUSSION
Our systematic review demonstrates that existing evidence on 
the association between multiple exclusions and health is domi-
nated by cross- sectional studies examining a limited number 
of exposure combinations and outcomes. In particular, we 
found there is a predominance of studies on infectious disease, 
mental illness and external causes of morbidity and mortality. 
Few studies have examined combinations involving sex work 
or more than two of these experiences. Results of our narrative 
and quantitative synthesis suggested that multiple exclusions are 
associated with increased all- cause and external- cause mortality, 
as well as higher prevalence of BBV. For NCDs, few data points 
were available, and associations varied by NCD type, exposure 
combination and outcome measure.
The skew of previous research towards specific exposure 
combinations and outcomes means that available evidence may 
not reflect the population overlap between these experiences or 
conditions causing the greatest burden of ill health. For instance, 
multiple exclusions appear to be associated with a higher risk of 
some NCDs, which may translate into a substantial population 
burden, yet these conditions were relatively understudied. These 
populations may therefore be further disadvantaged by evidence 
gaps on potentially important health needs.
Nonetheless, the available data demonstrate stark health 
inequalities. An estimated, 57% greater hazard of mortality 
associated with multiple exclusions, beyond the eightfold to 
12- fold differential seen between people with any one of such 
experience and the rest of the population,3 suggests extreme 
health disadvantage among these populations. The findings of 
excess risk of infections, and of comorbidities such as respiratory 
disease, are especially noteworthy in the context of the current 
COVID-19 pandemic.
The mechanisms by which intersecting forms of social exclu-
sion may influence health are likely to be complex. Multiple 
exclusions may worsen health through multiplicative or additive 
risks or even improve it by enabling access to services with bene-
ficial effects. Alternatively, the combination of these experiences 
may pose no additional risk (particularly where background risk 
is already high) or merely represent a marker for other forms 
of cumulative adversity with effects on health, such as extreme 
poverty.
The strengths of this review include its comprehensive scope, 
systematic and transparent approach and use of best practice 
guidelines for narrative synthesis.22 To our knowledge, no other 
review to date has attempted to synthesise the evidence of health 
outcomes associated with multiple forms of social exclusion in 
this way.
However, a number of limitations to our review should be 
noted. Given the large number of studies identified, we were 
unable to explore diversity within exposure categories in detail: 
for instance, homelessness encompasses a spectrum of housing 
exclusion from rough sleeping to ‘sofa surfing’. The nature of 
these experiences—and their relationship with health—is also 
likely to vary across contexts with different welfare regimes, 
healthcare systems and legislative approaches: this may 
further contribute to heterogeneity and merits more detailed 
investigation.
Another potential limitation is the risk of publication bias. 
Inspection of funnel plots suggested potential for small- study 
effects (online supplemental appendix 5), though this may be 
explained by true heterogeneity or methodological weaknesses 
of smaller studies.
Our findings cannot be used to draw conclusions about the 
causal effects of multiple exclusionary experiences, since few of 
the original studies used designs appropriate to causal inference, 
and to enhance comparability, our data extraction focused on 
minimally adjusted measures. Further work is required to estab-
lish the extent and nature of potential causal mechanisms.
Nonetheless, descriptive epidemiology can provide insights 
into ways to mitigate observed health inequalities. For instance, 
the high rates of external- cause mortality identified here suggest 
an important role for overdose, suicide and accident preven-
tion interventions in justice settings, temporary accommodation 
and mental healthcare. Existing services and policies tend to be 
narrowly focused on single experiences: a phenomenon particu-
larly well documented in mental healthcare, where people with 
substance use problems are often excluded from services.24 Our 
results suggest a more integrated approach may be warranted. 
Descriptive epidemiology can also provide baseline data for eval-
uating policy and service changes with the potential to impact 
health.25 26
Future research in this area would benefit from being informed 
by conceptual and empirical understandings of multiple exclu-
sions: for instance, by prioritising combinations that are most 
common or associated with poorest outcomes. There is also a 
need for more longitudinal research examining more than two 
overlapping experiences and for a greater focus on the potential 
burden of NCDs.
However, there are also important opportunities for action 
on the available evidence. While people affected by multiple 
exclusions represent a relatively small group within society, 
the extreme health inequalities identified here mean that their 
experiences and needs should be an important consideration 
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Figure 5 (A) Summary effect direction plot for external mortality (ICD-10 chapters 19 and 20) (B). Forest plot for meta- analysis of data points 
reporting external- cause mortality using HRs, by exposure combination.
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within healthcare systems, public health and public policy more 
broadly. This is especially pertinent during the global COVID-19 
pandemic, in which these populations face a ‘perfect storm’ of 
clinical and social vulnerability.27–29
CONCLUSION
Evidence to date suggests that people affected by multiple 
exclusionary processes experience profound health inequalities, 
though there are also important gaps in the research landscape. 
In particular, there is a need for studies examining a broader 
range of exposure combinations and outcomes, especially 
NCDs, and exploring possible causal mechanisms. In the mean-
time, addressing the health needs of these populations is likely 
to require co- ordinated action across multiple sectors, such as 
healthcare, criminal justice, drug treatment, housing and social 
security.
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What is already known on this subject
 ► Previous studies have shown that people experiencing 
homelessness, imprisonment, sex work, substance use or 
serious mental illness experience high levels of ill health and 
premature death.
 ► However, these experiences are known to overlap 
substantially in the population, a phenomenon variously 
referred to as multiple exclusions, severe and multiple 
disadvantage and multiple and complex needs. There is 
empirical and theoretical evidence to suggest that this 
overlap may matter for health.
 ► The association between more than one of these experiences 
and health outcomes has not previously been systematically 
reviewed.
What this study adds
 ► Our synthesis of existing evidence suggests that people 
affected by more than one of these exclusionary experiences 
have substantially poorer health outcomes—in terms of 
mortality, morbidity and self- rated health/quality of life.
 ► This review has also identified important gaps in the 
literature. Future research in this field should prioritise 
longitudinal designs examining a broader range of 
combinations and outcomes, particularly non- communicable 
diseases, and exploring heterogeneity within exposures.
 ► While in population terms the number of people affected by 
multiple exclusionary processes may be relatively small, they 
appear to experience extreme health inequalities. Addressing 
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